Continuous subcutaneous insulin infusion (CSII) is the most advanced form of insulin administration but requires structured education to provide users with the necessary knowledge/skills and motivation support. CSII offers significant advantages over traditional therapy, but at higher costs, it has been recognized for decades as an integral component of diabetes therapy. Aims: To evaluate the impact in first nine months in Structured Education Program for CSII users in Specialized Center.
September 2018 to March 2019, we followed 46 Type 1 Diabetes Patients treated in Specialized Center in the Standardized Structured Education Program, specifically developed for CSII users, providing the necessary skills and knowledge for the effective use of this resource and dealing with Psychological barriers to enhance the beneficial effects of the therapy.
66% women, average age 22,9 years. Mean glycemic values in the target ranges: < 54 mg/dL ranged from 3.7 to 6.9%; 55-69 mg/dL ranged from 7.87 to 4.4%; 70-180 mg/dL ranged from 46.2 to 56.1; 181-249 mg/dL that ranged from 17.27 to 18.0; > 250 mg/dL ranged from 24.67 to 11.4. The mean A1C ranged from 8.7% (5,8%-12,8%) to 7.8% (5.5-10.8%).
Reduction of 0,92% in A1C, with improvement in target ranges, increase in range of 70-180 and decrease in others. Clinical benefits and cost-effectiveness are only possible with the care structuring, trained professionals and skilled user to make appropriate decisions, managing problems, assessing and acting based on blood glucose.